¥¹¥¿¥Ã¥Õ
Éû±¡Ä¹À¶¿åÁï»Ö
¾¼ÏÂ61ǯÆÁÅçÂç³ØÂ´
°å³ØÇî»Î¡¦ÆüËÜÀ°·Á³°²Ê³Ø²ñÀìÌç°å¡¦ÆüËÜÀÔÄÇÀÔ¿ñɳزñ»ØÆ³°å¡¦ÆüËܥꥦ¥Þ¥Á³Ø²ñǧÄê°å
ÉôĹ»ÔÀîůÌé
Ê¿À®8ǯÉ;¾°å²ÊÂç³ØÂ´
ÆüËÜÀ°·Á³°²Ê³Ø²ñÀìÌç°å
°åĹ»³²¼ÂçÊå
Ê¿À®17ǯÉ;¾°å²ÊÂç³ØÂ´
°å°÷±±°æ³Ù
Ê¿À®18ǯ´ä¼ê°å²ÊÂç³ØÂ´
Èó¾ï¶Ð°å»ÕĹÌî¾¼
É;¾°å²ÊÂç³ØÀ°·Á³°²Ê̾ÍÀ¶µ¼ø
Èó¾ï¶Ð°å»ÕµÚÀîÆ»Íº
Áí¹çÀÄ»³É±¡Éû±¡Ä¹
¿ÇÎÅÆâÍÆ
À°·Á³°²Ê¤Ï»Í»è³°½ý¡¢¹ü´ØÀá¼À´µ¡¢ÀÔÄÇ¡¦ÀÔ¿ñ¼À´µ¡¢Ëö¾¿¿À·Ð¼À´µ¤Ê¤É¤ò°·¤¦¿ÇÎŲʤǤ¹¡£Ê¿À®23ǯ4·î¸½ºß¤ÏÀ¶¿åÁï»Ö¡¢ »ÔÀîůÌé¡¢»³²¼ÂçÊå¡¢±±°æ³Ù¤Î¾ï¶Ð4¿ÍÂÎÀ©¤Ç¿ÇÎŤò¹Ô¤Ã¤Æ¤ª¤ê¡¢À¶¿å¤ÏÀÔÄÇ¡¦ÀÔ¿ñ¼À´µ¤ò¡¢»ÔÀ´ØÀá¼À´µ¡¢ »³²¼¤¬¾®»ùÀ°·Á¼À´µ¤òôÅö¤·¤Æ¤¤¤Þ¤¹¡£
ÀÔÄÇ¡¦ÀÔ¿ñ¼À´µ¤Ïºòǯ112·ï¤Î¼ê½Ñ¤¬¤¢¤ê¡¢ÎãǯÄ̤êºÇ¤â¿¤«¤Ã¤¿¤Î¤¬¹âÎð²½¼Ò²ñ¤òÈ¿±Ç¤·¤¿¹øÉôÀÔÃì´É¶¹ºõ¾É¼ê½Ñ¤Ç¤·¤¿¡£ ¤Ç¤¤ë¤À¤±½Ñ¸åáÖÄˤξ¯¤Ê¤¤ÀÔÄǼê½Ñ¤ò¥Æ¡¼¥Þ¤Ë¼è¤êÁȤó¤Ç¤ª¤ê¡¢¸åÊý½ü°µ½Ñ¤Ï22з¤ΥÁ¥å¡¼¥Ö¥ì¥È¥é¥¯¥¿¡¼¤ò»ÈÍѤ·¤¿ ¸²Èù¶À¼ê½Ñ¤ò¹Ô¤Ã¤Æ¤¤¤Þ¤¹¡£½ÑÍâÆü¤â¤·¤¯¤ÏÍ⡹Æü¤«¤éÊâ¹Ô³«»Ï¡¢¥³¥ë¥»¥Ã¥È¤ÎɬÍפâ̵¤¯¡¢Ä̾½µ´ÖÁ°¸å¤ÇÂౡ²Äǽ¤È ¤Ê¤ê¤Þ¤¹¡£ÊÑÀ¤¹¤Ù¤ê¤äÊÑÀ¦׿¤Ê¤É¤ÎÀÔÃìÊÑÀ¤Ë´Ø¤·¤Æ¤Ï¡¢¸ÇÄê½Ñ¤¬É¬ÍפȤʤ뤳¤È¤¬Â¿¤¤¤Î¤Ç¤³¤Î¸Â¤ê¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¹øÄˤ䲼»è¾É¾õ¤Ç³°Íè¤òˬ¤ì¤ë´µ¼Ô¤µ¤ó¤Ïǯ¡¹Áý²Ã¤·¤Æ¤¤¤Þ¤¹¤¬¡¢¤Û¤È¤ó¤É¤ÎÊý¤Ï°ÂÀÅ¡¢ÌôʪÎÅË¡¤Ê¤É¤ÎÊݸÎÅË¡¤Ç ²þÁ±¤·¤Æ¤¤¤¤Þ¤¹¡£¤³¤ì¤é¤Î¾É¾õ¤Ç¤ªÇº¤ß¤ÎÊý¤Ï¤É¤¦¤¾¤ªµ¤·Ú¤Ë¤´ÁêÃ̤¯¤À¤µ¤¤¡£
´ØÀá¼À´µ¤Ç¤Ï¡¢É¨¡¢¸Ô´ØÀá¤Ê¤É¤Î¥È¥é¥Ö¥ë¤ÈÊÑ·ÁÀ´ØÀá¾É¡¢¸ª´ØÀáÄË¡¢´ØÀá¥ê¥¦¥Þ¥Á¤Î¼£ÎŤËÎϤòÆþ¤ì¤Æ¤ª¤ê¤Þ¤¹¡£ ³°Íè¤Ç¤ÎÊݸ²ÃÎŤò´ðËܤȤ·¤Æ¡¢¼ê½Ñ²ÃÎŤ¬É¬ÍפǤ¢¤ì¤Ð¿×®¤ËÂбþ¤·¤Þ¤¹¡£É¨¡¢¸ª¤Î´ØÀá¶À¼ê½Ñ¤Ï¼ê½Ñ¿¯½±¤¬¾¯¤Ê¤¯¡¢ ¿ÇÃǤȼ£ÎŤË͸ú¤Ç¤¢¤êÀѶËŪ¤Ë¹Ô¤Ã¤Æ¤ª¤ê¤Þ¤¹¡£É¨¡¢¸Ô´ØÀá¤Î¿Í¹©´ØÀáÃÖ´¹½Ñ¤ÏËö´üÊÑ·ÁÀ´ØÀá¾É¤Î½üÄˤËÍ¥¤ì¡¢ ¼ê½Ñ·ï¿ô¤âÁý²Ã¤·¤Æ¤ª¤ê¤Þ¤¹¡£Åö±¡¤Ç¤Ï½Ñ¸å1½µ¤ÇÊâ¹Ô¤¬¤Ç¤¡¢3¡Á4½µÄøÅÙ¤ÎÆþ±¡¥ê¥Ï¥Ó¥ê²ÃÎŤˤè¤ê ²ÈÄíÉüµ¢¤·¤Æ¤¤¤¿¤À¤¤¤Æ¤ª¤ê¤Þ¤¹¡£Ä¹´ü´Ö²þÁ±¤Î¤Ê¤¤´ØÀáÄˤˤªÇº¤ß¤ÎÊý¤ÏÀ§Èó¤´ÁêÃ̲¼¤µ¤¤¡£
Ëè½µ²ÐÍËÆü¤Ë¤ÏĹÌî¾¼ÀèÀ¸¡ÊÉ;¾°åÂçÀ°·Á³°²Ê̾ÍÀ¶µ¼ø¡Ë¤Î¿ÇÎŤ¬¤¢¤ê¤Þ¤¹¡£¾å»èµ¡Ç½ºÆ·ú½Ñ¡¢Ëö¾¿¿À·Ð¼ê½Ñ¤Ê¤É¤ò ¼¹Åᤷ¤Æ¤¤¤¿¤À¤¤¤Æ¤¤¤Þ¤¹¡£ÏÓ¿À·ÐÁÑËãá㡢ʬÊÚËãáã¡¢¤½¤Î¾Ëö¾¿¿À·Ð¾ã³²¤ÎÀ¤³¦Åª¸¢°Ò¤Ç¤¹¤Î¤Ç¼õ¿Ç¤´´õ˾¤ÎÊý¤Ï À°·Á³°²Ê³°Íè¤Þ¤Ç¤ªÌ䤤¹ç¤ï¤»¤¯¤À¤µ¤¤¡£
¼ç¤ÊÂоݼÀ´µ
ÊÑ·ÁÀ´ØÀá¾É¡¢ËýÀ´ØÀá¥ê¥¦¥Þ¥Á¡¢ÊÑ·ÁÀÀÔÄǾɡ¢¹øÄǤª¤è¤Ó·ÛÄÇÄÇ´ÖÈĥإë¥Ë¥¢¡¢¹øÉôÀÔÃì´É¶¹ºõ¾É¡¢¹üÀÞ¡¢¿ÙÂÓ»½ý¡¢ç§Â»½ý¡¢Ëö¾¿¿À·Ð¼À´µ¡¢¤½¤Î¾¹ü´ØÀá¼À´µ°ìÈÌ
¿ÇÎżÂÀÓ
| Ê¿À®22ǯ¼ê½Ñ·ï¿ô | |
|---|---|
| ÀÔÄÇ | 112Îã |
| ÂçÂܹü¶á°ÌÉô¹üÀÞ | 86Îã |
| ¤½¤Î¾»Í»è³°½ý | 74Îã |
| ´ØÀá¶À¼ê½Ñ | 45Îã |
| ´¶À÷¾É¡¢²õáÔ | 27Îã |
| ¿Í¹©´ØÀá | 25Îã |
| Ëö¾¿¿À·Ð | 15Îã |
| ¼ðáç | 10Îã |
| È´Å£¡¢ç§¾ä±ê¡¢¤½¤Î¾ | 66Îã |
| ¹ç·× | 460·ï |
¶ÈÀÓ
³Ø²ñȯɽ Âè220²óÀ°·Á³°²Ê½¸Ã̲ñÅ쳤ÃÏÊý²ñ¡ÊÊ¿À®22ǯ6·î¡Ë ´ØÀáÆâ´ØÀáÍ·Î¥ÂΤˤè¤ëº¬´É¾É¸õ·²¤Î1Îã ¿¹²¬Áï¡¡À¶¿åÁï»Ö¡¡»ÔÀîůÌé¡¡»³²¼ÂçÊ塡ĹÌî¾¼
Âè222²óÀ°·Á³°²Ê½¸Ã̲ñÅ쳤ÃÏÊý²ñ¡ÊÊ¿À®22ǯ12·î¡Ë ÂçÂܹü·ÛÉô¹üÀÞ¤ËÂФ¹¤ëDual SC Screw¥·¥¹¥Æ¥à¤Î¼£ÎÅÀ®ÀÓ ±±°æ³Ù¡¡À¶¿åÁï»Ö¡¡»ÔÀîůÌé¡¡»³²¼ÂçÊå
ÏÀʸ Rheumatol Int 30 : 725-730 , 2010 Etanersept treatment reduceces the serum levels of interleukin-15 and interferon-gamma inducible protein-10 Tetuya Ichikawa , Yasunori Kageyama , Hayato Kobayashi , Norihiko Kato ,Kunio Tsujimura , Yukio Koide
³°Íè¿ÇÎÅɽ
| ·î | ²Ð | ¿å | ÌÚ | ¶â | ÅÚ | |
|---|---|---|---|---|---|---|
| 8:30¡Á11:30 |
»ÔÀî ±±°æ |
ĹÌî »³²¼or±±°æ |
»ÔÀî |
À¶¿å ±±°æ |
À¶¿å »³²¼ |
¸òÂå ¸òÂå |
| 8:30¡Á11:30 ͽÌó |
À¶¿å |
»ÔÀî |
±±°æ |
»³²¼ |
||
| 2:00¡Á4:00 ͽÌó |
ĹÌî |
¡¡ |
Âè4½µ |
¢¨ÅÚÍËÆü¤Ï£²¿Ç¤ÇÀ¶¿å¡¢±±°æ¡¢»³²¼¤Î¸òÂåÀ©¤Ç¤¹
¢¨¸á¸å³°Íè¤ÏͽÌóÀ©¤Ç¤¹
¢¨ÌÚÍËÆü¤Î½é¿Ç³°Íè¤Ï¼ê½Ñ¤Î¤¿¤á¸á¸å3:00¡Á5:00¤ËÊѹ¹¤Ë¤Ê¤ë¤³¤È¤¬¤¢¤ê¤Þ¤¹